» Articles » PMID: 36364516

Enhanced Diabetic Wound Healing Using Electrospun Biocompatible PLGA-Based Saxagliptin Fibrous Membranes

Overview
Date 2022 Nov 11
PMID 36364516
Authors
Affiliations
Soon will be listed here.
Abstract

Delayed diabetic wound healing is an adverse event that frequently leads to limb disability or loss. A novel and promising vehicle for the treatment of diabetic wounds is required for clinical purposes. The biocompatible and resorbable poly (lactic-co-glycolic acid) (PLGA)-based fibrous membranes prepared by electrospinning that provide a sustained discharge of saxagliptin for diabetic wound healing were fabricated. The concentration of released saxagliptin in Dulbecco’s phosphate-buffered saline was analyzed for 30 days using high-performance liquid chromatography. The effectiveness of the eluted saxagliptin was identified using an endothelial progenitor cell migration assay in vitro and a diabetic wound healing in vivo. Greater hydrophilicity and water storage were shown in the saxagliptin-incorporated PLGA membranes than in the pristine PLGA membranes (both p < 0.001). For diabetic wound healing, the saxagliptin membranes accelerated the wound closure rate, the dermal thickness, and the heme oxygenase-1 level over the follicle areas compared to those in the pristine PLGA group at two weeks post-treatment. The saxagliptin group also had remarkably higher expressions of insulin-like growth factor I expression and transforming growth factor-β1 than the control group (p = 0.009 and p < 0.001, respectively) in diabetic wounds after treatment. The electrospun PLGA-based saxagliptin membranes exhibited excellent biomechanical and biological features that enhanced diabetic wound closure and increased the antioxidant activity, cellular granulation, and functionality.

Citing Articles

Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications.

Benitez-Camacho J, Ballesteros A, Beltran-Camacho L, Rojas-Torres M, Rosal-Vela A, Jimenez-Palomares M Stem Cell Res Ther. 2023; 14(1):324.

PMID: 37950274 PMC: 10636846. DOI: 10.1186/s13287-023-03537-8.


Stretchable Sensors: Novel Human Motion Monitoring Wearables.

Cho C, Chung P, Tsai Y, Yang Y, Lin S, Huang P Nanomaterials (Basel). 2023; 13(16).

PMID: 37630960 PMC: 10459719. DOI: 10.3390/nano13162375.


Electrospun Fibrous Silica for Bone Tissue Engineering Applications.

Stoica Oprea A, Birca A, Gherasim O, Ficai A, Grumezescu A, Oprea O Pharmaceutics. 2023; 15(6).

PMID: 37376176 PMC: 10304373. DOI: 10.3390/pharmaceutics15061728.


In Vitro Antioxidant and Fibroblast Migration Activities of Fractions Eluded from Dichloromethane Leaf Extract of .

Balachandran A, Siyumbwa S, Froemming G, Beata M, Malgorzata J, Lavilla Jr C Life (Basel). 2023; 13(6).

PMID: 37374190 PMC: 10304334. DOI: 10.3390/life13061409.


Nanofibrous insulin/vildagliptin core-shell PLGA scaffold promotes diabetic wound healing.

Lee C, Chen D, Hsieh M, Hung K, Huang S, Cho C Front Bioeng Biotechnol. 2023; 11:1075720.

PMID: 37168611 PMC: 10164987. DOI: 10.3389/fbioe.2023.1075720.

References
1.
Vagnozzi A, Reiter J, Wong S . Hair follicle and interfollicular epidermal stem cells make varying contributions to wound regeneration. Cell Cycle. 2015; 14(21):3408-17. PMC: 4825603. DOI: 10.1080/15384101.2015.1090062. View

2.
Jin P, Zhang X, Wu Y, Li L, Yin Q, Zheng L . Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc. 2010; 42(7):2745-52. DOI: 10.1016/j.transproceed.2010.05.145. View

3.
Lee C, Hsieh M, Liu S, Chen J, Liu S, Hsieh I . Novel bifurcation stents coated with bioabsorbable nanofibers with extended and controlled release of rosuvastatin and paclitaxel. Mater Sci Eng C Mater Biol Appl. 2018; 88:61-69. DOI: 10.1016/j.msec.2018.02.027. View

4.
Roy S, Metya S, Rahaman N, Sannigrahi S, Ahmed F . Ferulic acid in the treatment of post-diabetes testicular damage: relevance to the down regulation of apoptosis correlates with antioxidant status via modulation of TGF-β1, IL-1β and Akt signalling. Cell Biochem Funct. 2013; 32(1):115-24. DOI: 10.1002/cbf.2983. View

5.
Long M, Cai L, Li W, Zhang L, Guo S, Zhang R . DPP-4 Inhibitors Improve Diabetic Wound Healing via Direct and Indirect Promotion of Epithelial-Mesenchymal Transition and Reduction of Scarring. Diabetes. 2017; 67(3):518-531. DOI: 10.2337/db17-0934. View